Back to Journals » Journal of Asthma and Allergy » Volume 8

Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases

Total article views   HTML views PDF downloads Totals
22,188 Dovepress* 16,680+ 2,825 19,505
PubMed Central* 5,508 1,624 7,132
Totals 22,188 4,449 26,637
*Since 8 October 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 4 4

View citations on PubMed Central and Google Scholar